FDA Investigator Theressa B Smith

Theressa B Smith has conducted inspections on 280 sites in 12 countries as of 10 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
280
Last Inspection Date:
10 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Germany, United Kingdom of Great Britain and Northern Ireland, India, Switzerland, China, Australia, Italy, Ghana, Canada, Brazil, France
FDA Investigators that have inspected at least one site in common with Theressa B Smith:
Alan M Barker, Alan P Kurtzberg, Alanna L Mussawwir Bias, Albert F Peacock, PhD, Alexander M Kay, Alia Legaux, Alicia A Armijo, Allen F Hall, Amanda E Lewin, PhD, Ana C Lazo, Andrace L Deyampert, Andrea J Schmidt, Andrea S Heise, Andrew M Kolenc, Anthony J Lagreca, Ashleigh P Barkans, Ashleigh P Wodushek, Astrid M Rylander, Azotearc, Barbara D Wright, Barbara J White, Barbara Janine Breithaupt, Barbara M Frazier, Betty Kay Baxter, Blake R Jensen, Brandon K Lawson, Brandy D Brown, Brent W Higgs, Brett R Havranek, Brittany R Laymon, Bryan A Galvez, Bryan J Love, Bryce A Hammer, Byungja E Marciante, Carl J Montgomery, Carla R Hinz, Carmen Ramirez, Carmen Y Fisher, Caroline H Le, Carolyn J Cook, Carrie E Jolly, CDR Rochelle B Young, RPh, MSA, Chelsea N Sealey, Chet A Fitzgerald, Christin L Torres, Christina A Mayer, Christine I Shaw, Christine L Williams, Christopher J Adams, Christopher J Freebairn, Conor J Mccarron, Courtney N Long, Courtney R Bratina, Cynthia Jim, CSO, Cynthia L Rakestraw, Daniel J Lahar, Daniel L Aisen, Daniel Pst Laurent, Darla J Christopher, David A Gonzalez, Dawn C Olenjack, Deborah S Hammond, Debra L Curtis, Debra Lboyd Seale, Diana K Krepel, Dianna D Wardlow Dotter, Donald R Hawn, Dr. Abhijit Raha, PhD, Dr. Carmelo Rosa, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Duc Minh H Nguyen, Dustin M James, Dustin P Tran, Edith M Gonzalez, Edward D Mcdonald, Edward J Janik, Elaine G Stewart, Elisa J Beard, Elizabeth D Gonzales, Elvin R Smith, Emily B Camire, Eric L Vangraafeiland, Eric M Mueller, PharmD, Eric R Holm, Eric S Myskowski, Erica R Havely, Erica R Woody, Erika V Butler, Erin M Mcdowell, Erma Zaimova, Ernest Serna, III, Felix J Marrero, Francis J Eng, Frank L Cordova, Frans E Mercado, Frederick L Fricke, Gail L Katz, Gajendiran Mahadevan, PhD, Gary C Pecic, Jr, Gene D Arcy, Genoula K Ryan, George A Prager, Gerald B Seaborn, Jr, Gerard T Schneider, Gina M Scholze, Ginger M Sykes, Gloria A Milster, Grace E Mcnally, Gulshan R Anand, Gunneet Kaur, Gwyn G Dickinson, Hanna L Potter, Haroon Vohra (NMI), Harry A Wilson, Helen R Bester, Holly L Miller, Hong Song, Hugh M Mcclure, II, Ingrid A Zambrana, Iram R Hassan, PhD, Isabel Y Espinosa, Isaiah D Isakson, Jacqueline Mdiaz Albertini, James D Bradley, James D Romero, James L Dunnie, Jr, James P Stallings, James R Montero, Jamie L Dion, Janet Pulver, Janete A Oliveira, Janete F Guardia, Jeanne J Thai, Jennifer A Baker, Jennifer A Kinney, Jennifer A Robinson, Jennifer C Adams, Jennifer L Wolfe, Jennifer M Gogley, Jennifer M Pouget, Jennifer R Mathern, Jennifer S Arce, Jessica M Ector, Jessie E Morris, Joan A Loreng, Joanne M Schlossin, Joel D Hustedt, John A Gonzalez, John A Iwen, Jonathan R Campos, Joo Jin, Jose R Hernandez, Joseph R Lambert, Joshua A Querl, Juan A Morales, Julia D Cartwright, Junho Pak, Justin R Carr, Kamara Co, Karen A Wolnik, Karen G Hirshfield, Karen M Montgomery (KMM), Karen Wolnik, Katherine Szestypalow, Kathleen S Tormey, Kathryn A Krentz, Kathryn M Mogen, Keith C Littrell, Kelley L Clark, Kelly D Moore, Kent C Faul, Kevin D Kallander, Khumo A Phake, Kimberley A Hoefen, Kimberly A Peterson, Kimetha A King, Kip J Hanks, Kristen E Szenderski, Lakecha N Lewis, Lan T Tran, Lance Mde Souza, MBA, Larisa E Pavlick, Larry Gehring, Laura B Kennedy, Laura L Staples, Laura L Van Wagenen, Lauren R Howell, Lavender M Huskey, Lawrence E Schaufler, LCDR Ismael Olvera, IV, Lesley Maep Lutao, Lewis K Antwi, Li Hongpaul Yeh, PhD, Lillie M Young, Linda F Murphy, Linda M Cheny, Linda R Kuchenthal, Linda Thai, Lori A Carr, Lori A Gioia, Manuel A Moreno, Marc A Jackson, Jr, Marcus F Yambot, Marie B Buen Bigornia, Marijo B Kambere, PhD, Marion W Nadeau, Mark S Frank, Marsha L Mccauley, Martina E Lagrange, Mary F Bodick, Matthew A Johnson, Matthew A Kozler, Matthew J Gretkierewicz, Matthew J Hansen, Matthew M Vernon, Matthew R Dionne, Megan A Haggerty, Melissa F Chauvin, Melissa J Nucci, Melsomar R Ramos, Michael A Blaine, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael Kuchta, Michael L Zimmerman, Michael R Goga, Michelle D Motsinger, Miguel A Martinez Perez, Mihaly S Ligmond, Mitzi A Schwertfeger, Mohsen Rajabi Abhari, FDA, Moonn, Morie Alpha, Nancy L Neiger, Nathan M Jornod, Nathan R Moon, Nayan J Patel, Neira Acevedo Ramos, Nicola M Fenty Stewart, Nicole J Clausen, Oluwaseyi Ojinni, Omotunde O Osunsanmi, Patricia A Brown, Patricia A Cortez, Patricia A Maestas, Patricia Brown, Patricia D Stahnke, Patricia M Jacobs, Paul J Teitell, Paul Klug, Paul M Chefor, Paul Z Balcer, Paula J Bretz, Peter R Lenahan, Philip E Ake, Rafael H Ortiz, Randy L Clarida, Randy V Bong, Rebecca H Lee, Rebecca L Mullikin, Rebecca S Secrist, Richard W Clark, Ricki A Chase, Robert Sharpnack, Roberta W Cunningham, Robles, Rose Xu, Rowena S Nguyen, Ruth A Williams, Saied A Asbagh, Sajin Bae, Sam H Haidar, PhD, Samantha E Rafferty, Samantha J Pinizzotto, D V M, Samson O Oluseye, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Scott B Laufenberg, Secrist, Sheila Alaghemand, Shelley H Beausoleil, Shererk, Sheri L Stephenson, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stefanie R Cook, Stephen T Hansen, Steve P Yost, Steven C Madzo, Steven O Gauthier, Stuart W Russell, Sunitha K Rajaram, PhD, Susan L Young, Susan M Jackson, Tamara L Setzer, Tawny L Colling, Teena H Aiken, Tenzin Jangchup, Terri L Thomas, Thai T Duong, Theressa B Madison, Thomas W Gordon, Thomas W Nojek, Tiara Nbrown Crosen, Toni L Morales, Trevor R Beach, Trinidad D Barreras, Vickie J Kanion, Vicky L Cruz, Wayne W Grundstrom, William A Lanier, William D Boden, Yvette Mlacour Davis, Zachary A Bogorad, Zachary L Miller, Zachary L Stamm, Zerita White, Zhongren Wu

Theressa B Smith's Documents

Publish Date Document Type Title
December, 2009 FDA 483 TOLMAR, INC - Form 483, 2009-12-11
July, 2021 FDA 483 Nancy A. Krywonis, M.D. - Form 483, 2021-07-23
March, 2013 EIR Lovelace Biomedical Research Institute - EIR, 2013-03-13
June, 2014 EIR Sky Ridge Medical Center - EIR, 2014-06-30
May, 2013 FDA 483 Colorado Histo-Prep - Form 483, 2013-05-28
September, 2018 FDA 483 Response HEATHER R. HARRISON, D.O. - Form 483R, 2018-10-05
March, 2022 FDA 483 HMS Veterinary Development Inc - Form 483, 2022-03-17
March, 2015 EIR Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - EIR, 2015-03-13
August, 2003 FDA 483 BPL Plasma, Inc. - Form 483, 2003-08-01
June, 2018 FDA 483 Esoterix Clinical Trials Services - Form 483, 2018-06-27
June, 2018 FDA 483 Response Esoterix Clinical Trials Services - Form 483R, 2018-07-11
July, 2022 FDA 483 Samm Solutions, Inc (dba) BTS Research - Form 483, 2022-07-21
March, 2013 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2013-03-13
February, 2018 EIR Cochlear Americas Inc. - EIR, 2018-02-22
July, 2019 FDA 483 Ryan M. Rich, M.D. - Form 483, 2019-07-29
February, 2019 FDA 483 Barrett E. Cowan, MD - Form 483, 2019-02-05
March, 2020 EIR National Jewish Health - EIR, 2020-03-09
February, 2017 FDA 483 Ivy, David Dunbar M.D. - Form 483, 2017-04-06
March, 2020 FDA 483 Southwest Bio-Labs, Inc. - Form 483, 2020-03-19
January, 2020 FDA 483 Response Lovelace Biomedical Research Institute - Form 483R, 2020-02-20
May, 2019 FDA 483 Michael W. Harris, D.O. - Form 483, 2019-05-24
November, 2016 EIR Lovelace Biomedical Research Institute - EIR, 2016-11-11
July, 2014 FDA 483 Response CARE Research, LLC - Form 483R, 2014-08-13
November, 2016 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2016-11-11
November, 2017 FDA 483 Janet Thomas, M.D. - Form 483, 2017-11-27
June, 2018 EIR Esoterix Clinical Trials Services - EIR, 2018-09-11
February, 2023 FDA 483 Redbeast Enterprises Inc dba High Quality Research - Form 483, 2023-02-27
February, 2023 FDA 483 Response Redbeast Enterprises Inc dba High Quality Research - Form 483R, 2023-03-20
April, 2017 FDA 483 Levin, Myron J., M.D. - Form 483, 2017-04-27
September, 2018 FDA 483 HEATHER R. HARRISON, D.O. - Form 483, 2018-10-05
May, 2021 FDA 483 Jayant Kumar, M.D. - Form 483, 2021-05-10
August, 2016 FDA 483 Southwest Bio-Labs, Inc. - Form 483, 2016-08-29
July, 2008 FDA 483 Response Sandoz Incorporated - Form 483R, 2008-08-01
February, 2018 FDA 483 Cochlear Americas Inc. - Form 483, 2018-02-22
May, 2013 FDA 483 Pyxant Labs - Form 483, 2013-05-17
May, 2023 FDA 483 Arthur R. Cabrera, M.D. - Form 483, 2023-05-16
July, 2021 EIR Nancy A. Krywonis, M.D. - EIR, 2021-07-23
July, 2008 FDA 483 Sandoz Incorporated - Form 483, 2008-07-03
September, 2019 FDA 483 Carl B. Tubbs, M.D. - Form 483, 2019-10-28
September, 2018 FDA 483 Response Ryser, Mark R., D.M.D. - Form 483R, 2018-10-05
April, 2022 FDA 483 Creighton University IRB - Form 483, 2022-04-12
April, 2018 FDA 483 Nicholas O. Opoku, MD - Form 483, 2018-04-06
May, 2013 FDA 483 Response Colorado Histo-Prep - Form 483R, 2013-05-27
April, 2017 EIR Levin, Myron J., M.D. - EIR, 2017-04-21
December, 2023 FDA 483 Allen Cohn - Form 483, 2024-02-04
August, 2021 FDA 483 Smitha Reddy, M.D. - Form 483, 2021-09-23
August, 2021 EIR Smitha Reddy, M.D. - EIR, 2021-08-20
February, 2011 FDA 483 Fresenius Medical Care North America - Form 483, 2011-02-04
March, 2020 FDA 483 National Jewish Health - Form 483, 2020-03-09
June, 2018 FDA 483 Paul W. Wallace, MD - Form 483, 2018-06-08
February, 2011 FDA 483 New Vistas Inc. - Form 483, 2011-02-28
August, 2006 FDA 483 Replidyne, Inc. - Form 483, 2006-08-08
June, 2023 FDA 483 Namita A. Goyal, M.D. - Form 483, 2023-07-23
July, 2020 FDA 483 Karsh, Lawrence, M.D. - Form 483, 2020-07-30
May, 2019 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2019-06-12
January, 2020 FDA 483 Lovelace Biomedical Research Institute - Form 483, 2020-01-31
May, 2013 EIR Colorado Histo-Prep - EIR, 2013-05-10
September, 2018 FDA 483 Ryser, Mark R., D.M.D. - Form 483, 2018-09-18
July, 2008 EIR Sandoz Incorporated - EIR, 2008-07-03
December, 2022 FDA 483 Barbara E. Rizzardi, MD - Form 483, 2022-12-06
December, 2000 FDA 483 Apria Healthcare, Inc - Form 483, 2000-12-18
May, 2013 EIR Pyxant Labs - EIR, 2013-05-17
March, 2015 FDA 483 Response Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - Form 483R, 2015-04-03
May, 2015 FDA 483 Colorado Histo-Prep - Form 483, 2015-05-19
December, 2019 FDA 483 Patel, Vikas V. - Form 483, 2019-12-17
December, 2017 FDA 483 David Young, D.O. - Form 483, 2017-12-19
August, 2023 FDA 483 Lewis, Karl D. MD - Form 483, 2023-09-12
March, 2023 FDA 483 Nicola Longo, M.D., Ph.D. - Form 483, 2023-03-10
March, 2015 FDA 483 Clinogent (A Division of GVK Biosciences Pvt. Ltd.) - Form 483, 2015-03-13
January, 2020 EIR Lovelace Biomedical Research Institute - EIR, 2020-01-31
July, 2009 FDA 483 Neoteric Cosmetics, Incorporated - Form 483, 2009-07-09
October, 2021 FDA 483 Cochlear Americas Inc. - Form 483, 2021-10-21
July, 2024 FDA 483 Neurocrine Biosciences Inc - Form 483, 2024-07-18

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more